Imai A - Search Results

1

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Tanaka T, Yoneyama T, Noro D, Imanishi K, Kojima Y, Hatakeyama S, Tobisawa Y, Mori K, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Kurauchi S, Takahashi I, Ohyama C. Tanaka T, et al. Among authors: imai a. Int J Mol Sci. 2017 Dec 6;18(12):2632. doi: 10.3390/ijms18122632. Int J Mol Sci. 2017. PMID: 29210993 Free PMC article.

2

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Anan G, Yoneyama T, Noro D, Tobisawa Y, Hatakeyama S, Sutoh Yoneyama M, Yamamoto H, Imai A, Iwamura H, Kohada Y, Mikami J, Ito J, Kaiho Y, Yoneyama T, Hashimoto Y, Sato M, Ohyama C. Anan G, et al. Among authors: imai a. Int J Mol Sci. 2019 Dec 21;21(1):93. doi: 10.3390/ijms21010093. Int J Mol Sci. 2019. PMID: 31877766 Free PMC article.

3

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Hashimoto Y, Okamoto A, Imai A, Yoneyama T, Hatakeyama S, Yoneyama T, Koie T, Kaminura N, Ohyama C. Hashimoto Y, et al. Among authors: imai a. Int J Clin Oncol. 2012 Apr;17(2):119-23. doi: 10.1007/s10147-011-0267-6. Epub 2011 Jun 16. Int J Clin Oncol. 2012. PMID: 21678041 Clinical Trial.

4

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y. Koie T, et al. Among authors: imai a. Med Oncol. 2014 May;31(5):949. doi: 10.1007/s12032-014-0949-9. Epub 2014 Apr 4. Med Oncol. 2014. PMID: 24700028 Free PMC article.

5

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Yoneyama T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C. Yoneyama T, et al. Among authors: imai a. Int J Clin Oncol. 2015 Apr;20(2):369-74. doi: 10.1007/s10147-014-0706-2. Epub 2014 May 29. Int J Clin Oncol. 2015. PMID: 24865474

6

Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.

Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K. Koie T, et al. Among authors: imai a. Urol Oncol. 2014 Aug;32(6):820-5. doi: 10.1016/j.urolonc.2014.03.010. Epub 2014 Jun 18. Urol Oncol. 2014. PMID: 24951323

7

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y. Koie T, et al. Among authors: imai a. Med Oncol. 2015 Jan;32(1):421. doi: 10.1007/s12032-014-0421-x. Epub 2014 Dec 4. Med Oncol. 2015. PMID: 25471790

8

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K. Koie T, et al. Among authors: imai a. BMC Urol. 2015 Apr 16;15:32. doi: 10.1186/s12894-015-0027-4. BMC Urol. 2015. PMID: 25887125 Free PMC article.

9

Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.

Yoneyama T, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C. Yoneyama T, et al. Among authors: imai a. Int J Clin Oncol. 2015 Dec;20(6):1179-84. doi: 10.1007/s10147-015-0846-z. Epub 2015 May 26. Int J Clin Oncol. 2015. PMID: 26007690

10

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K. Koie T, et al. Among authors: imai a. Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7. Int Urol Nephrol. 2015. PMID: 26149637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

914 results

Search Page